boceprevir [Ligand Id: 7876] activity data from GtoPdb and ChEMBL
Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL218394 (Boceprevir, EBP 520, EBP-520, SCH 503034, SCH-503034, Victrelis) |
|---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| cathepsin B/Cathepsin B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4072] [GtoPdb: 2343] [UniProtKB: P07858] | ||||||||
| ChEMBL | Inhibition of human CatB after 60 mins fluorescence assay | B | 5.21 | pIC50 | 6200 | nM | IC50 | Antimicrob Agents Chemother (2010) 54: 4611-4618 [PMID:20823284] |
| ChEMBL | Inhibition of human Cathepsin B | B | 5.48 | pIC50 | >3300 | nM | IC50 | Antimicrob Agents Chemother (2010) 54: 305-311 [PMID:19841155] |
| cathepsin F/Cathepsin F in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2517] [GtoPdb: 2347] [UniProtKB: Q9UBX1] | ||||||||
| ChEMBL | Inhibition of human Cathepsin F | B | 5.96 | pIC50 | 1100 | nM | IC50 | Antimicrob Agents Chemother (2010) 54: 305-311 [PMID:19841155] |
| cathepsin K/Cathepsin K in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL268] [GtoPdb: 2350] [UniProtKB: P43235] | ||||||||
| ChEMBL | Inhibition of human Cathepsin K | B | 7.4 | pIC50 | 40 | nM | IC50 | Antimicrob Agents Chemother (2010) 54: 305-311 [PMID:19841155] |
| cathepsin L/Cathepsin L in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3837] [GtoPdb: 2351] [UniProtKB: P07711] | ||||||||
| ChEMBL | Inhibition of human Cathepsin L | B | 6.12 | pIC50 | 760 | nM | IC50 | Antimicrob Agents Chemother (2010) 54: 305-311 [PMID:19841155] |
| cathepsin V/Cathepsin L2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3272] [GtoPdb: 2352] [UniProtKB: O60911] | ||||||||
| ChEMBL | Inhibition of human Cathepsin V | B | 7.12 | pIC50 | 75 | nM | IC50 | Antimicrob Agents Chemother (2010) 54: 305-311 [PMID:19841155] |
| cathepsin S/Cathepsin S in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2954] [GtoPdb: 2353] [UniProtKB: P25774] | ||||||||
| ChEMBL | Inhibition of human cathepsin S | B | 4 | pIC50 | >100000 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 6325-6330 [PMID:24135727] |
| ChEMBL | Inhibition of human Cathepsin S | B | 6.92 | pIC50 | 120 | nM | IC50 | Antimicrob Agents Chemother (2010) 54: 305-311 [PMID:19841155] |
| chymase 1/Chymase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4068] [GtoPdb: 2340] [UniProtKB: P23946] | ||||||||
| ChEMBL | Inhibition of human Chymase | B | 7.49 | pIC50 | 32 | nM | IC50 | Antimicrob Agents Chemother (2010) 54: 305-311 [PMID:19841155] |
| chymotrypsin like elastase 1/Elastase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3000] [GtoPdb: 2338] [UniProtKB: Q9UNI1] | ||||||||
| ChEMBL | Inhibition of human Pancreatic elastase 1 | B | 5 | pIC50 | >10000 | nM | IC50 | Antimicrob Agents Chemother (2010) 54: 305-311 [PMID:19841155] |
| Hepatitis C virus serine protease, NS3/NS4A in Hepatitis C virus (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2095231] [UniProtKB: A3EZI9, D2K2A8] | ||||||||
| ChEMBL | Inhibition of HCV genotype 1a NS3/4A protease using Ac-DED(Edans)EEAbu-psi[COO]ASK(Dabcyl)-NH2 as substrate by FRET assay | B | 7.85 | pKi | 14 | nM | Ki | Bioorg Med Chem (2014) 22: 6595-6615 [PMID:25456385] |
| elastase, neutrophil expressed/Leukocyte elastase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL248] [GtoPdb: 2358] [UniProtKB: P08246] | ||||||||
| ChEMBL | Inhibition of human neutrophil elastase | B | 4 | pIC50 | >=100000 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 6325-6330 [PMID:24135727] |
| ChEMBL | Inhibition of human leukocyte elastase after 60 mins fluorescence assay | B | 4.77 | pIC50 | 17000 | nM | IC50 | Antimicrob Agents Chemother (2010) 54: 4611-4618 [PMID:20823284] |
| ChEMBL | Inhibition of human Neutrophil elastase 2 | B | 5 | pIC50 | >10000 | nM | IC50 | Antimicrob Agents Chemother (2010) 54: 305-311 [PMID:19841155] |
| NS3 in Hepatitis C virus (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1293269] [UniProtKB: A3EZJ3] | ||||||||
| ChEMBL | Binding affinity at HCV NS3 protease | B | 7.85 | pKi | 14 | nM | Ki | J Med Chem (2006) 49: 6074-6086 [PMID:17004721] |
| plasminogen/Plasminogen in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1801] [GtoPdb: 2394] [UniProtKB: P00747] | ||||||||
| ChEMBL | Inhibition of human plasmin | B | 4 | pIC50 | >100000 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 6325-6330 [PMID:24135727] |
| coagulation factor II, thrombin/Thrombin in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL204] [GtoPdb: 2362] [UniProtKB: P00734] | ||||||||
| ChEMBL | Inhibition of human thrombin | B | 6 | pIC50 | <1000 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 6325-6330 [PMID:24135727] |
| Cathepsin A in Human [GtoPdb: 1581] [UniProtKB: P10619] | ||||||||
| GtoPdb | - | - | 6 | pIC50 | 1000 | nM | IC50 | WO2013072327. Use of boceprevir and related compounds in atherosclerosis, heart failure, renal diseases, liver diseases or inflammatory diseases. (2013) |
| CoV 3C-like (main) protease in SARS-CoV [GtoPdb: 3111] [UniProtKB: P0C6U8] | ||||||||
| GtoPdb | - | - | 6.02 | pIC50 | 949 | nM | IC50 |
Nature Research (2020) : ; PLoS One (2021) 16: e0245962 [PMID:33524017] |
ChEMBL data shown on this page come from version 33:
Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]
